Pumpless Microfluidic Organ-on-a-Chip Immune Interaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro testing systems fail to accurately predict human and mammalian responses to chemicals due to their inability to mimic the dynamic dose dynamics and interactions between tissue compartments, missing mechanical forces, and the complexity of immune responses, leading to ethical and efficacy challenges in drug development and toxicity assessment.
Innovation Solution
A pumpless microfluidic system that mimics organ systems with immune cells circulating in a serum-free medium, allowing for the interaction of organ cells with immune cells under conditions that simulate physiological responses, including the use of multiple organ chambers and sensors to monitor cellular functions and immune responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If static multi-well plate systems are used for in vitro testing, then device complexity is reduced, but the ability to mimic physiological dose dynamics and mechanical forces is lost
Solution Approach 1:
The patent implements dynamic fluid flow through microfluidic channels that simulate blood circulation, creating time-dependent chemical concentration changes and mechanical shear forces on cells. This dynamic environment replaces static multi-well plates while maintaining manageable complexity through integrated chip design.
Solution Approach 2:
The system uses microfluidic hydraulic flow to deliver chemicals and nutrients to organ cells, mimicking physiological blood flow. This hydraulic approach enables realistic dose dynamics and mechanical forces without requiring complex external pumping systems for each well.
2Device complexity
If isolated single cell or tissue types are used in static wells, then device complexity is minimized, but the ability to capture metabolite exchange between tissue compartments is lost
Solution Approach 1:
The system segments different organ tissues into separate microfluidic chambers (liver, kidney, heart, lung, brain) that are connected through fluid flow paths. This segmentation allows each tissue to be cultured separately while maintaining the ability to exchange metabolites through the simulated circulation system, capturing systemic interactions without overwhelming complexity.
Solution Approach 2:
The microfluidic chip serves multiple functions simultaneously: it acts as a culture platform for different organ cells, a delivery system for chemicals and nutrients, a collection system for metabolites, and a model for physiological flow. This multi-functionality integrates metabolite exchange capability without proportionally increasing device complexity.
3Device complexity
If traditional in vitro testing without immune cells is used, then device complexity is reduced, but the ability to predict immune responses and inflammation is lost
Solution Approach 1:
The patent merges immune cell culture with organ cell culture in the same microfluidic system. Immune cells are introduced into the circulation alongside organ cells, allowing direct interaction and immune response monitoring. This combination captures immune-systemic interactions while maintaining a single integrated device rather than separate complex systems.
Data Source
AI summary
A pumpless microfluidic system is disclosed that can be used to mimic the interaction of organ systems with the immune system. Also disclosed is a method for mimicking an immune system, comprising culturing a plurality of organ cells and at least one population of immune cells in the disclosed pumpless microfluidic system under physiological conditions. The method can further comprise activating an immune reaction in the pumpless microfluidic system, continuing the culture for a defined period, collecting a sample of culture medium from the system, and assaying the sample for one or more indicators of an immune response.